BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26639240)

  • 1. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population.
    Svajdler M; Kaspirkova J; Mezencev R; Laco J; Torday T; Dubinsky P; Straka L; Ondic O; Michal M; Skalova A
    Neoplasma; 2016; 63(1):107-14. PubMed ID: 26639240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of human papillomavirus on nasopharyngeal carcinoma in Japan.
    Kano M; Kondo S; Wakisaka N; Moriyama-Kita M; Nakanishi Y; Endo K; Murono S; Nakamura H; Yoshizaki T
    Auris Nasus Larynx; 2017 Jun; 44(3):327-332. PubMed ID: 27499435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of oncogenic human papilloma virus and Epstein-Barr virus prevalence in Turkish nasopharyngeal cancer patients.
    Tatlı Doğan H; Kılıçarslan A; Doğan M; Süngü N; Güler Tezel G; Güler G
    Pathol Res Pract; 2016 Nov; 212(11):1021-1026. PubMed ID: 27640103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
    Simon J; Schroeder L; Ingarfield K; Diehl S; Werner J; Brenner N; Liu Z; Pawlita M; Pring M; Butt J; Ness A; Waterboer T
    Int J Cancer; 2020 Jul; 147(2):461-471. PubMed ID: 32279316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
    Ruuskanen M; Irjala H; Minn H; Vahlberg T; Randen-Brady R; Hagström J; Syrjänen S; Leivo I
    Head Neck; 2019 Feb; 41(2):349-357. PubMed ID: 30549170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Value of the Epstein-Barr Virus and p16 Status in Patients with Nasopharyngeal Carcinoma: A Single-Centre Study in Japan.
    Saito Y; Ushiku T; Omura G; Yasuhara K; Yoshida M; Takahashi W; Ando M; Fukayama M; Yamasoba T
    ORL J Otorhinolaryngol Relat Spec; 2016; 78(6):334-343. PubMed ID: 28171876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein-Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction.
    Punwaney R; Brandwein MS; Zhang DY; Urken ML; Cheng R; Park CS; Li HB; Li X
    Head Neck; 1999 Jan; 21(1):21-9. PubMed ID: 9890347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
    Feng G; Xu Y; Ma N; Midorikawa K; Oikawa S; Kobayashi H; Nakamura S; Ishinaga H; Zhang Z; Huang G; Takeuchi K; Murata M
    BMC Cancer; 2021 Aug; 21(1):929. PubMed ID: 34407796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population.
    Dogan S; Hedberg ML; Ferris RL; Rath TJ; Assaad AM; Chiosea SI
    Head Neck; 2014 Apr; 36(4):511-6. PubMed ID: 23780921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis.
    Simon J; Brenner N; Reich S; Langseth H; Hansen BT; Ursin G; Ferreiro-Iglesias A; Brennan P; Kreimer AR; Johansson M; Pring M; Nygard M; Waterboer T
    Cancer Epidemiol; 2022 Apr; 77():102117. PubMed ID: 35121404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed Death-Ligand 1 Expression, Microsatellite Instability, Epstein-Barr Virus, and Human Papillomavirus in Nasopharyngeal Carcinomas of Patients from the Philippines.
    Chang AMV; Chiosea SI; Altman A; Pagdanganan HA; Ma C
    Head Neck Pathol; 2017 Jun; 11(2):203-211. PubMed ID: 27807760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans.
    Maxwell JH; Kumar B; Feng FY; McHugh JB; Cordell KG; Eisbruch A; Worden FP; Wolf GT; Prince ME; Moyer JS; Teknos TN; Chepeha DB; Stoerker J; Walline H; Carey TE; Bradford CR
    Head Neck; 2010 May; 32(5):562-7. PubMed ID: 19757421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients.
    Lin Z; Khong B; Kwok S; Cao H; West RB; Le QT; Kong CS
    Head Neck; 2014 May; 36(5):709-14. PubMed ID: 23616441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The correlation of human papillomavirus and EB virus infection in nasopharyngeal carcinoma in Fujian].
    Yang F; Huang S; Wang M; Li J; Chen X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Aug; 28(15):1122-5. PubMed ID: 25322598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis.
    Stenmark MH; McHugh JB; Schipper M; Walline HM; Komarck C; Feng FY; Worden FP; Wolf GT; Chepeha DB; Prince ME; Bradford CR; Mukherji SK; Eisbruch A; Carey TE
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):580-8. PubMed ID: 24521676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral markers in nasopharyngeal carcinoma: A systematic review and meta-analysis on the detection of p16
    Tham T; Machado R; Russo DP; Herman SW; Teegala S; Costantino P
    Am J Otolaryngol; 2021; 42(1):102762. PubMed ID: 33202328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population.
    Chen WJ; Xu WN; Wang HY; Chen XX; Li XQ; Xie SH; Lin DF; Cao SM
    BMC Cancer; 2021 Jun; 21(1):651. PubMed ID: 34074258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
    Guo J; Cui Z; Zheng Y; Li X; Chen Y
    Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
    Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
    EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.
    Ruuskanen M; Leivo I; Minn H; Vahlberg T; Haglund C; Hagström J; Irjala H
    BMC Cancer; 2019 Jun; 19(1):624. PubMed ID: 31238894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.